Most Read Articles
2 days ago
Dairy consumption during adolescence or early adulthood does not appear to be associated with the overall risk of breast cancer, although results vary by hormone receptor status of tumours, a study has shown. Specifically, dairy intake is linked to higher ER–/PR– and lower ER+/PR+ cancer risk.
Roshini Claire Anthony, 5 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

3 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
4 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Protein supplement twice daily ups strength, lean mass in older men

31 Jul 2017

Protein-based, multi-ingredient nutritional supplements, consumed twice daily, increase lean mass and muscle strength in older males, a new trial has found.

The study included 49 healthy elderly males (mean age 73±1 years; mean body mass index, 28.5±1.5 kg/m2) randomized to receive either the nutritional supplement (n=25) or a control drink (n=24). Participants received supplements or controls alone for the first 6 weeks (phase 1) and underwent an added exercise training for the next 6 weeks (phase 2).

In phase 1, the supplement group showed a 3-percent increase in the sum of all one repetition maximums (1RM) from 206±7kg at baseline to 212±8 kg after 6 weeks (p<0.001). Isotonic muscle strength increased a further 20 percent after phase 2 (p<0.001).

After phase 1, the supplement group showed significant increases in whole-body (0.7 kg; p<0.001), appendicular (0.4 kg; p<0.01), leg (0.3 kg; p<0.01) and trunk (0.4 kg; p=0.002) lean mass. No further increases were observed after phase 2.

No significant changes in strength in the control group was observed during phase 1. Sum of all 1RMs increased by 21 percent (p<0.001) after phase 2. The observed changes in lean body mass in either phase were nonsignificant.

The nutritional supplement used contained whey protein, calcium, omega-3 polyunsaturated fatty acids, creatinine and vitamin D. Control drinks had maltodextrin. Supplements or controls were taken twice daily for 20 weeks.

The exercise regimen consisted of resistance exercise training twice weekly and high-intensity interval training once weekly. Dual-energy x-ray absorptiometry was used to measure body composition.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Dairy consumption during adolescence or early adulthood does not appear to be associated with the overall risk of breast cancer, although results vary by hormone receptor status of tumours, a study has shown. Specifically, dairy intake is linked to higher ER–/PR– and lower ER+/PR+ cancer risk.
Roshini Claire Anthony, 5 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

3 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
4 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.